Cargando…

The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic

BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively sprea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Juen Kiem, Leong, Dalleen, Munusamy, Hemalatha, Zenol Ariffin, Nor Hazwani, Kori, Najma, Hod, Rozita, Periyasamy, Petrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942693/
https://www.ncbi.nlm.nih.gov/pubmed/33750347
http://dx.doi.org/10.1186/s12879-021-05849-7
_version_ 1783662365953228800
author Tan, Juen Kiem
Leong, Dalleen
Munusamy, Hemalatha
Zenol Ariffin, Nor Hazwani
Kori, Najma
Hod, Rozita
Periyasamy, Petrick
author_facet Tan, Juen Kiem
Leong, Dalleen
Munusamy, Hemalatha
Zenol Ariffin, Nor Hazwani
Kori, Najma
Hod, Rozita
Periyasamy, Petrick
author_sort Tan, Juen Kiem
collection PubMed
description BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively spreading the disease unknowingly whilst undetected. However, lengthy lockdowns and isolation leads to a host of socioeconomic issues and are impractical. Conversely, there exists no study describing this group and their clinical significance despite their key role in disease transmission. METHODS: As a result, we devised a retrospective study to look at the prevalence of presymptomatic patients with COVID-19 from data sourced via our medical records office. Subsequently, we identify early indicators of infection through demographic information, biochemical and radiological abnormalities which would allow early diagnosis and isolation. In addition, we will look into the clinical significance of this group and their outcome; if it differs from asymptomatic or symptomatic patients. Descriptive statistics were used in addition to tabulating the variables and corresponding values for reference. Variables are compared between the presymptomatic group and others via Chi-square testing and Fisher’s exact test, accepting a p value of < 0.05 as significant. RESULTS: Our analysis shows a higher proportion of presymptomatic patients with atypical symptoms like chest pain while symptomatic patients commonly present with respiratory symptoms like cough and shortness of breath. Besides that, there were more females presenting as presymptomatic patients compared to males (p = 0.019) and these group of patients were likely to receive treatment (p < 0.001). Otherwise, we were not able to identify other statistically significant markers suggesting a patient is presymptomatic. CONCLUSION: As we have little means of identifying these silent spreaders, it highlights further the importance of general measures implemented to stop COVID-19 transmission like social distancing, face mask, and widespread testing.
format Online
Article
Text
id pubmed-7942693
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79426932021-03-10 The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic Tan, Juen Kiem Leong, Dalleen Munusamy, Hemalatha Zenol Ariffin, Nor Hazwani Kori, Najma Hod, Rozita Periyasamy, Petrick BMC Infect Dis Research Article BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively spreading the disease unknowingly whilst undetected. However, lengthy lockdowns and isolation leads to a host of socioeconomic issues and are impractical. Conversely, there exists no study describing this group and their clinical significance despite their key role in disease transmission. METHODS: As a result, we devised a retrospective study to look at the prevalence of presymptomatic patients with COVID-19 from data sourced via our medical records office. Subsequently, we identify early indicators of infection through demographic information, biochemical and radiological abnormalities which would allow early diagnosis and isolation. In addition, we will look into the clinical significance of this group and their outcome; if it differs from asymptomatic or symptomatic patients. Descriptive statistics were used in addition to tabulating the variables and corresponding values for reference. Variables are compared between the presymptomatic group and others via Chi-square testing and Fisher’s exact test, accepting a p value of < 0.05 as significant. RESULTS: Our analysis shows a higher proportion of presymptomatic patients with atypical symptoms like chest pain while symptomatic patients commonly present with respiratory symptoms like cough and shortness of breath. Besides that, there were more females presenting as presymptomatic patients compared to males (p = 0.019) and these group of patients were likely to receive treatment (p < 0.001). Otherwise, we were not able to identify other statistically significant markers suggesting a patient is presymptomatic. CONCLUSION: As we have little means of identifying these silent spreaders, it highlights further the importance of general measures implemented to stop COVID-19 transmission like social distancing, face mask, and widespread testing. BioMed Central 2021-03-09 /pmc/articles/PMC7942693/ /pubmed/33750347 http://dx.doi.org/10.1186/s12879-021-05849-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tan, Juen Kiem
Leong, Dalleen
Munusamy, Hemalatha
Zenol Ariffin, Nor Hazwani
Kori, Najma
Hod, Rozita
Periyasamy, Petrick
The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title_full The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title_fullStr The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title_full_unstemmed The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title_short The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
title_sort prevalence and clinical significance of presymptomatic covid-19 patients: how we can be one step ahead in mitigating a deadly pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942693/
https://www.ncbi.nlm.nih.gov/pubmed/33750347
http://dx.doi.org/10.1186/s12879-021-05849-7
work_keys_str_mv AT tanjuenkiem theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT leongdalleen theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT munusamyhemalatha theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT zenolariffinnorhazwani theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT korinajma theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT hodrozita theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT periyasamypetrick theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT tanjuenkiem prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT leongdalleen prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT munusamyhemalatha prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT zenolariffinnorhazwani prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT korinajma prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT hodrozita prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic
AT periyasamypetrick prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic